Clinical studies of induction agents XLIII: Flunitrazepam

11Citations
Citations of this article
10Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Summary: Flunitrazepam (Ro 5-4200) has been studied as an induction agent in 220 volunteers or patients. It was assumed to be 10 times as potent as diazepam. The maximum soporific effect did not occur until 90-120 s after injection. There was great individual variation in response to flunitrazepam and some patients did not lose consciousness even after receiving 6 mg (approximately 0.1 mg/kg). Opiate premedication enhanced its action, but delayed recovery. There was a dose-related increase in minor respiratory upset with flunitrazepam in unpremedicated patients and a high frequency of arterial hypotension following large doses given to patients who had received opiate premedication. Venous sequelae were no more frequent than after comparable doses of diazepam. Flunitrazepam was not a very satisfactory drug for the induction of anaesthesia, and recovery was too prolonged for routine use. © 1976 Macmillan Journals Ltd.

Cite

CITATION STYLE

APA

Dundee, J. W., Varadarajan, C. R., Gaston, J. H., & Clarke, R. S. J. (1976). Clinical studies of induction agents XLIII: Flunitrazepam. British Journal of Anaesthesia, 48(6), 551–555. https://doi.org/10.1093/bja/48.6.551

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free